Tevogen Bio Holdings Inc (TVGN)

Finanzdaten der Tevogen Bio Holdings Inc-Aktie (TVGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.84%5.66	5.40	4.61	5.73	5.44
Research and Development	4.71%3.28	3.13	2.11	3.11	2.70
Operating Income/Loss	4.84%-5.66	-5.40	-4.61	-5.73	-5.44
Net Interest Income/Expense	38.25%-0.10	-0.07	-0.07	-0.06	-0.04
	5.80%-5.76	-5.45	-4.68	-5.73	-5.50
Attributable To Parent	5.80%-5.76	-5.45	-4.68	-5.73	-5.50
Available To Common Stockholders, Basic	3.89%-5.84	-5.62	-4.82	-5.86	-5.64
Basic Average Shares	9.84%3.83	3.49	-	196.03	184.31
Diluted Average Shares	9.84%3.83	3.49	-	196.03	184.31
Basic Earnings Per Share	5.59%-1.52	-1.61	-	-0.03	-0.03
Diluted Earnings Per Share	5.59%-1.52	-1.61	-	-0.03	-0.03